ARCHIVES

ImClone Offered C225 Deal To Seven Firms Prior To BMS

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

Susan Sieber, Former NCI Communications Chief, Dead.

January 25, 2002

Hawaii Gets CBCCP Award

August 12, 1977